Linden Thomas Advisory Services, LLC Gilead Sciences, Inc. Transaction History
Linden Thomas Advisory Services, LLC
- $988 Billion
- Q3 2025
A detailed history of Linden Thomas Advisory Services, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Linden Thomas Advisory Services, LLC holds 48,274 shares of GILD stock, worth $5.99 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
48,274
Previous 47,527
1.57%
Holding current value
$5.99 Million
Previous $5.27 Billion
1.69%
% of portfolio
0.54%
Previous 0.58%
Shares
12 transactions
Others Institutions Holding GILD
# of Institutions
2,367Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...